Activity of the novel BCR kinase inhibitor IQS019 in preclinical models of B-cell non-Hodgkin lymphoma

Overview of attention for article published in Journal of Hematology & Oncology, March 2017

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 336 followers.

Activity of the novel BCR kinase inhibitor IQS019 in preclinical models of B-cell non-Hodgkin lymphoma. https://t.co/Y7qxhslM07 #jhoonline

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.